Skip to main content

MARSHALL WACE, LLP

Position in ACIU — AC Immune SA

CIK 1318757 LONDON, X0

Position in ACIU

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$361,509
-$224,756 QoQ
Shares Held
131,458
-29.6% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACIU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. ACIU ranks #245 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACIU

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $361,509 131,458
2025-12-31 $586,265 186,709
2025-06-30 $275,756 135,841
2025-03-31 $396,783 212,184
2024-12-31 $179,057 66,318
2024-09-30 $375,633 99,374
2021-12-31 $43,832 8,855
2021-09-30 $391,716 58,378
2020-06-30 $180,162 26,770
2020-03-31 $512,998 74,240